EMA to publish and enable access to clinical trial data

Friday, August 17, 2012 09:27 AM

The European Medicines Agency (EMA) will proactively publish clinical trial data and enable access to full data sets by interested parties.

A number of practical and policy issues need to be addressed before complex data sets can be made available. The EMA will hold a workshop in November to listen to the views, interests and concerns from a broad range of institutions, groups and individuals. The results will help it define the modalities of proactive access to clinical trial data, in an open and transparent forum. Registration is open until Oct. 31, with attendance limited to 150.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs